JP2007505836A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505836A5 JP2007505836A5 JP2006526431A JP2006526431A JP2007505836A5 JP 2007505836 A5 JP2007505836 A5 JP 2007505836A5 JP 2006526431 A JP2006526431 A JP 2006526431A JP 2006526431 A JP2006526431 A JP 2006526431A JP 2007505836 A5 JP2007505836 A5 JP 2007505836A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- immune response
- kit
- composition according
- proteosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002163 immunogen Effects 0.000 claims 26
- 239000000427 antigen Substances 0.000 claims 11
- 102000036639 antigens Human genes 0.000 claims 11
- 108091007433 antigens Proteins 0.000 claims 11
- 241000712079 Measles morbillivirus Species 0.000 claims 8
- 230000028993 immune response Effects 0.000 claims 8
- 201000005505 Measles Diseases 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 4
- 230000016379 mucosal immune response Effects 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 3
- 238000003259 recombinant expression Methods 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 2
- 101710169105 Minor spike protein Proteins 0.000 claims 2
- 101710081079 Minor spike protein H Proteins 0.000 claims 2
- 241000588650 Neisseria meningitidis Species 0.000 claims 2
- 230000036755 cellular response Effects 0.000 claims 2
- 230000008348 humoral response Effects 0.000 claims 2
- 102000018358 immunoglobulin Human genes 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 241000607000 Plesiomonas Species 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 241000607768 Shigella Species 0.000 claims 1
- 241000607762 Shigella flexneri Species 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50311403P | 2003-09-15 | 2003-09-15 | |
| PCT/US2004/030361 WO2005027964A1 (en) | 2003-09-15 | 2004-09-15 | Measles subunit vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505836A JP2007505836A (ja) | 2007-03-15 |
| JP2007505836A5 true JP2007505836A5 (enExample) | 2007-11-22 |
Family
ID=34375312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526431A Withdrawn JP2007505836A (ja) | 2003-09-15 | 2004-09-15 | 麻疹サブユニットワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20050152919A1 (enExample) |
| EP (1) | EP1667713A1 (enExample) |
| JP (1) | JP2007505836A (enExample) |
| CA (1) | CA2538887A1 (enExample) |
| WO (1) | WO2005027964A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1372706B1 (en) * | 2001-03-09 | 2010-12-01 | ID Biomedical Corporation of Quebec | Proteosome-liposaccharide vaccine adjuvant |
| US7255867B2 (en) * | 2002-11-15 | 2007-08-14 | Id Biomedical Corporation Of Quebec | Vaccine |
| JP4966661B2 (ja) * | 2003-10-22 | 2012-07-04 | アイディー バイオメディカル コーポレイション オブ ケベック | 生得的免疫およびアレルギー性免疫を活性化させるための組成物および方法 |
| NZ578727A (en) * | 2004-06-25 | 2011-03-31 | Brigham & Womens Hospital | Proteosome compositions and methods for treating neurological disorders |
| WO2009132244A1 (en) * | 2008-04-25 | 2009-10-29 | Id Biomedical Corporation Of Quebec | Methods for preparing immunogenic compositions |
| JP2010122205A (ja) * | 2008-08-29 | 2010-06-03 | Sysmex Corp | 麻疹ウイルス検出方法、メンブレンアッセイ用試験具およびメンブレンアッセイ用試験キット |
| US10092642B2 (en) | 2013-10-03 | 2018-10-09 | Nitto Denko Corporation | Mucosal vaccine composition |
| JP6494233B2 (ja) * | 2013-10-03 | 2019-04-03 | 日東電工株式会社 | 粘膜ワクチン組成物 |
| CN105530953A (zh) * | 2013-10-03 | 2016-04-27 | 日东电工株式会社 | 注射疫苗组合物 |
| KR20160061989A (ko) | 2013-10-03 | 2016-06-01 | 닛토덴코 가부시키가이샤 | 코점막 백신 조성물 |
| TW201618790A (zh) * | 2014-10-02 | 2016-06-01 | Nitto Denko Corp | 經皮投與用疫苗醫藥組合物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
| US5726292A (en) * | 1987-06-23 | 1998-03-10 | Lowell; George H. | Immuno-potentiating systems for preparation of immunogenic materials |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
| PT854729E (pt) * | 1995-09-18 | 2004-08-31 | Us Army Med Res Mat Com Usamrm | Metodos melhorados para a producao de vacinas de subunidade multivalentes de proteossomas complexados nao covalentemente |
| US6080725A (en) * | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| NZ500779A (en) * | 1997-05-20 | 2001-06-29 | Galenica Pharmaceuticals Inc | Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| US6262029B1 (en) * | 1998-08-14 | 2001-07-17 | Galenica Pharmaceuticals, Inc. | Chemically modified saponins and the use thereof as adjuvants |
| EP1031347B1 (en) * | 1999-01-27 | 2002-04-17 | Idea Ag | Transnasal transport/immunisation with highly adaptable carriers |
| GB9925966D0 (en) * | 1999-11-02 | 1999-12-29 | Petrik Juraj | Threapeutic vaccines against variable viruses and other targets |
| DE19963124A1 (de) * | 1999-12-24 | 2001-07-12 | Roland Man Druckmasch | Reinigungsmedium und dessen Verwendung |
| AUPQ520800A0 (en) * | 2000-01-21 | 2000-02-17 | Alfred Hospital | Prime-boost vaccination strategy |
| JP3980884B2 (ja) * | 2000-02-15 | 2007-09-26 | アイディー バイオメディカル コーポレイション オブ ケベック | プロテオソーム・インフルエンザ・ワクチン |
| JP2003528068A (ja) * | 2000-03-17 | 2003-09-24 | コリクサ コーポレイション | 新規両親媒性アルデヒドならびにアジュバントおよび免疫エフェクターとしてのそれらの使用 |
| EP1372706B1 (en) * | 2001-03-09 | 2010-12-01 | ID Biomedical Corporation of Quebec | Proteosome-liposaccharide vaccine adjuvant |
-
2004
- 2004-09-15 JP JP2006526431A patent/JP2007505836A/ja not_active Withdrawn
- 2004-09-15 CA CA002538887A patent/CA2538887A1/en not_active Abandoned
- 2004-09-15 WO PCT/US2004/030361 patent/WO2005027964A1/en not_active Ceased
- 2004-09-15 US US10/941,634 patent/US20050152919A1/en not_active Abandoned
- 2004-09-15 EP EP04784276A patent/EP1667713A1/en not_active Withdrawn
-
2008
- 2008-07-29 US US12/182,047 patent/US20090175903A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009516529A5 (enExample) | ||
| JP3626684B2 (ja) | 抗原 | |
| Bakaletz et al. | Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla | |
| CA2438425A1 (en) | A novel proteosome-liposaccharide vaccine adjuvant | |
| JP2012501347A5 (enExample) | ||
| WO2002098369A2 (en) | Mutant forms of cholera holotoxin as an adjuvant | |
| JP2007505033A5 (enExample) | ||
| AU2002322380A1 (en) | Mutant forms of cholera holotoxin as an adjuvant | |
| JP2015536134A5 (enExample) | ||
| JP2006506989A5 (enExample) | ||
| JP2005511662A5 (enExample) | ||
| JP2006504644A5 (enExample) | ||
| Berlec et al. | Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity | |
| CN110891599A (zh) | 基于来自伤寒样沙门菌物种的两种不同菌株的外膜囊泡的肠热疫苗 | |
| Cui et al. | Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae | |
| JP2008523805A5 (enExample) | ||
| US7408044B2 (en) | Carrier protein having an adjuvant effect | |
| JP3169608B2 (ja) | ヒトにおいてエンテロトキシン産生大腸菌により起こる腸感染症／下痢に対して接種するためのホルマリン殺菌したコロニー形成因子抗原（ｃｆａ）−発現性大腸菌の調製および使用 | |
| CN1154660C (zh) | 热易变肠毒素和霍乱毒素b亚基之间的杂合分子 | |
| JP2002537352A5 (enExample) | ||
| JP2007509166A5 (enExample) | ||
| CN103409455B (zh) | 抗人源肠毒素大肠杆菌粘附素蛋白的卵黄抗体及其应用 | |
| WO1999047164A1 (en) | Use of mutant enterotoxin with excess b-subunit as an adjuvant | |
| WO1995009649A1 (en) | Vaccine compositions | |
| Xie et al. | Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine |